Home/Filings/4/0001140361-23-050615
4//SEC Filing

Ying Han 4

Accession 0001140361-23-050615

CIK 0001124105other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 6:15 AM ET

Size

5.2 KB

Accession

0001140361-23-050615

Insider Transaction Report

Form 4
Period: 2023-10-31
Ying Han
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-31+1,8661,866 total
    Exercise: $6.93Exp: 2033-10-31Common Stock (1,866 underlying)
Footnotes (1)
  • [F1]These options vest as to one-third on each of the first, second and third anniversaries of October 31, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file

Issuer

GYRE THERAPEUTICS, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001987630

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 6:15 AM ET
Size
5.2 KB